Amy E. McKee's most recent trade in Biocryst Pharmaceuticals Inc. was a trade of 676 Common Stock done at an average price of $8.3 . Disclosure was reported to the exchange on Aug. 29, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Biocryst Pharmaceuticals Inc | Amy E. McKee | Director | Grant, award, or other acquisition of securities at price $ 8.31 per share. | 29 Aug 2025 | 676 | 41,007 (0%) | 0% | 8.3 | 5,618 | Common Stock |
| Biocryst Pharmaceuticals Inc | Amy E. McKee | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2025 | 27,181 | 27,181 | - | - | Automatic Stock Option Grant | |
| Biocryst Pharmaceuticals Inc | Amy E. McKee | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2025 | 12,500 | 40,331 (0%) | 0% | 0 | Common Stock |